National Health Act, 2003 (Act No. 61 of 2003)

Regulations

Regulations relating to the Surveillance and the Control of Notifiable Medical Conditions, 2017

Annexures

Annexure A

Table 4 : List of category 4 notifiable medical conditions

Purchase cart Previous page Return to chapter overview Next page

 

Category 4 notifiable medical conditions to be notified through a written or electronic notification to the Department of Health within 1 month of diagnosis by private and public health laboratories:

 


Notifiable medical condition

Pathogen/s to notify

1.

Health care-associated infections or multi drug-resistant organisms of public health importance*

Carbapenemase-producing Enterobacteriaceae
Vancomycin-resistant enterococci
Staphylococcus aureus: hGISA and GISA
Colistin-resistant Pseudomonas aeruginosa
Colistin-resistant Achinetobacter baumanil
Clostridium difficile

 

*Health care-associated infection means an infection occurring in a patient during the process of care in a health establishment which was not present or incubating at the time of admission.

 

[Annexure A (Table 4) substituted by section 2 of Notice No. 6064, GG52391, dated 27 March 2025]